The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Small-Molecule Drug Discovery Market Research Report 2024

Global Small-Molecule Drug Discovery Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1713779

No of Pages : 82

Ask Your Query

Synopsis

Global Small-Molecule Drug Discovery market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Small-Molecule Drug Discovery market research.

Key companies engaged in the Small-Molecule Drug Discovery industry include Pfizer, Merck, Bristol-Myers Squibb, GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Teva Pharmaceuticals and Gilead Sciences Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Small-Molecule Drug Discovery were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Small-Molecule Drug Discovery market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Small-Molecule Drug Discovery market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List)

  •     Pfizer
  •     Merck
  •     Bristol-Myers Squibb
  •     GlaxoSmithKline
  •     Boehringer Ingelheim
  •     AstraZeneca
  •     Johnson & Johnson
  •     Teva Pharmaceuticals
  •     Gilead Sciences Inc.

Segment by Type

  •     Pills
  •     Tablets
  •     Others

Segment by Application

  •     Oncology
  •     Cardiovascular
  •     Dermatology
  •     Central Nervous System
  •     Respiratory
  •     Gastrointestinal
  •     Others

By Region

  •   North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

 

The Small-Molecule Drug Discovery report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

 

  1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Small-Molecule Drug Discovery Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Pills
        1.2.3 Tablets
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Small-Molecule Drug Discovery Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Dermatology
        1.3.5 Central Nervous System
        1.3.6 Respiratory
        1.3.7 Gastrointestinal
        1.3.8 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Small-Molecule Drug Discovery Market Perspective (2018-2029)
    2.2 Small-Molecule Drug Discovery Growth Trends by Region
        2.2.1 Global Small-Molecule Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Small-Molecule Drug Discovery Historic Market Size by Region (2018-2023)
        2.2.3 Small-Molecule Drug Discovery Forecasted Market Size by Region (2024-2029)
    2.3 Small-Molecule Drug Discovery Market Dynamics
        2.3.1 Small-Molecule Drug Discovery Industry Trends
        2.3.2 Small-Molecule Drug Discovery Market Drivers
        2.3.3 Small-Molecule Drug Discovery Market Challenges
        2.3.4 Small-Molecule Drug Discovery Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Small-Molecule Drug Discovery Players by Revenue
        3.1.1 Global Top Small-Molecule Drug Discovery Players by Revenue (2018-2023)
        3.1.2 Global Small-Molecule Drug Discovery Revenue Market Share by Players (2018-2023)
    3.2 Global Small-Molecule Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Small-Molecule Drug Discovery Revenue
    3.4 Global Small-Molecule Drug Discovery Market Concentration Ratio
        3.4.1 Global Small-Molecule Drug Discovery Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Small-Molecule Drug Discovery Revenue in 2022
    3.5 Small-Molecule Drug Discovery Key Players Head office and Area Served
    3.6 Key Players Small-Molecule Drug Discovery Product Solution and Service
    3.7 Date of Enter into Small-Molecule Drug Discovery Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Small-Molecule Drug Discovery Breakdown Data by Type
    4.1 Global Small-Molecule Drug Discovery Historic Market Size by Type (2018-2023)
    4.2 Global Small-Molecule Drug Discovery Forecasted Market Size by Type (2024-2029)

 5 Small-Molecule Drug Discovery Breakdown Data by Application
    5.1 Global Small-Molecule Drug Discovery Historic Market Size by Application (2018-2023)
    5.2 Global Small-Molecule Drug Discovery Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Small-Molecule Drug Discovery Market Size (2018-2029)
    6.2 North America Small-Molecule Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Small-Molecule Drug Discovery Market Size by Country (2018-2023)
    6.4 North America Small-Molecule Drug Discovery Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Small-Molecule Drug Discovery Market Size (2018-2029)
    7.2 Europe Small-Molecule Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Small-Molecule Drug Discovery Market Size by Country (2018-2023)
    7.4 Europe Small-Molecule Drug Discovery Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Small-Molecule Drug Discovery Market Size (2018-2029)
    8.2 Asia-Pacific Small-Molecule Drug Discovery Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Small-Molecule Drug Discovery Market Size by Region (2018-2023)
    8.4 Asia-Pacific Small-Molecule Drug Discovery Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Small-Molecule Drug Discovery Market Size (2018-2029)
    9.2 Latin America Small-Molecule Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Small-Molecule Drug Discovery Market Size by Country (2018-2023)
    9.4 Latin America Small-Molecule Drug Discovery Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Small-Molecule Drug Discovery Market Size (2018-2029)
    10.2 Middle East & Africa Small-Molecule Drug Discovery Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Small-Molecule Drug Discovery Market Size by Country (2018-2023)
    10.4 Middle East & Africa Small-Molecule Drug Discovery Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Small-Molecule Drug Discovery Introduction
        11.1.4 Pfizer Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.1.5 Pfizer Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck Small-Molecule Drug Discovery Introduction
        11.2.4 Merck Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.2.5 Merck Recent Development
    11.3 Bristol-Myers Squibb
        11.3.1 Bristol-Myers Squibb Company Detail
        11.3.2 Bristol-Myers Squibb Business Overview
        11.3.3 Bristol-Myers Squibb Small-Molecule Drug Discovery Introduction
        11.3.4 Bristol-Myers Squibb Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.3.5 Bristol-Myers Squibb Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Detail
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Small-Molecule Drug Discovery Introduction
        11.4.4 GlaxoSmithKline Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Detail
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Small-Molecule Drug Discovery Introduction
        11.5.4 Boehringer Ingelheim Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Detail
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Small-Molecule Drug Discovery Introduction
        11.6.4 AstraZeneca Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.6.5 AstraZeneca Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Detail
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Small-Molecule Drug Discovery Introduction
        11.7.4 Johnson & Johnson Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.7.5 Johnson & Johnson Recent Development
    11.8 Teva Pharmaceuticals
        11.8.1 Teva Pharmaceuticals Company Detail
        11.8.2 Teva Pharmaceuticals Business Overview
        11.8.3 Teva Pharmaceuticals Small-Molecule Drug Discovery Introduction
        11.8.4 Teva Pharmaceuticals Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.8.5 Teva Pharmaceuticals Recent Development
    11.9 Gilead Sciences Inc.
        11.9.1 Gilead Sciences Inc. Company Detail
        11.9.2 Gilead Sciences Inc. Business Overview
        11.9.3 Gilead Sciences Inc. Small-Molecule Drug Discovery Introduction
        11.9.4 Gilead Sciences Inc. Revenue in Small-Molecule Drug Discovery Business (2018-2023)
        11.9.5 Gilead Sciences Inc. Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock